Emgality

Emgality

galcanezumab

Manufacturer:

Eli Lilly

Distributor:

Zuellig
/
Agencia Lei Va Hong
Concise Prescribing Info
Contents
Galcanezumab
Indications/Uses
Prophylaxis of migraine in adults who have at least 4 migraine days per mth.
Dosage/Direction for Use
SC 120 mg once mthly, w/ 240 mg loading dose as initial dose.
Contraindications
Special Precautions
Discontinue treatment immediately in case of serious hypersensitivity reaction. No safety data in patients w/ major CV diseases. Minor influence on ability to drive & use machines. Preferable to avoid use during pregnancy. Consider use during breast-feeding only if clinically needed. Safety & efficacy in childn 6-18 yr have not yet been established. No relevant use in childn <6 yr. Limited information in elderly ≥65 yr.
Adverse Reactions
Inj site pain/reactions. Vertigo; constipation; pruritus, rash.
MIMS Class
Antimigraine Preparations
ATC Classification
N02CD02 - galcanezumab ; Belongs to the class of calcitonin gene-related peptide (CGRP) antagonists preparations. Used to relieve migraine.
Presentation/Packing
Form
Emgality soln for inj 120 mg/mL
Packing/Price
1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in